FDA-Drug2026-07-01Class IIPROCESSING DEFECT
Amgen Sensipar (cinacalcet) 90mg tablets recalled for manufacturing compliance issues
What this means
Amgen is recalling Sensipar (cinacalcet) 90mg tablets due to deviations from current good manufacturing practice (CGMP) standards. This affects one lot distributed nationwide. No injuries have been reported.
- Check if your Sensipar matches lot #1157056 (expiration 02/29/2028).
- Contact your pharmacy or doctor before stopping this medication.
- Return the affected medication to your pharmacy or follow your doctor's instructions.
The agency's original wording
Hazard
CGMP Deviations
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
1 Amgen Center Dr, N/A, Thousand Oaks, CA, United States
Products
Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0616-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.